Clinical Trial Update: AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating AtriCure's bipolar radiofrequency ablation for persistent atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AtriCure Bipolar Radiofrequency Ablation

Snippet

Sponsor: AtriCure, Inc. | Conditions: Atrial Fibrillation | Phase 3 | Status: WITHDRAWN